• / Free eNewsletters & Magazine
  • / My Account
Home>Sanofi Gets U.S. FDA Approval for Gaucher Disease Treatment

Sanofi Gets U.S. FDA Approval for Gaucher Disease Treatment

3party Content

Wed, 20 Aug 2014

By Inti Landauro PARIS--The U.S. Food and Drug Administration has given its approval to Sanofi SA's (SAN.FR) Cerdelga capsule for Gaucher disease, the French pharmaceutical company said. Gaucher disease is a genetic condition affecting the liver, spleen, kidneys, lungs, brain and bone marrow.
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.